Published in Kidney Int on August 01, 2007
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria | NCT00095290
Microalbuminuria Predicting CIAKI After CAG (MPCC) | NCT02808845
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ (2013) 3.98
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care (2009) 1.33
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens (2013) 0.93
Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study. ISRN Endocrinol (2011) 0.89
Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results. Hippokratia (2011) 0.86
Comparing angiotensin II receptor blockers on benefits beyond blood pressure. Adv Ther (2010) 0.84
Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. Indian J Nephrol (2011) 0.83
The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension. Sci Rep (2014) 0.81
Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease. Chin Med J (Engl) (2016) 0.80
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? Cardiovasc Diabetol (2013) 0.79
Long-term use and tolerability of irbesartan for control of hypertension. Integr Blood Press Control (2011) 0.78
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders. Drugs (2016) 0.77
Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease. Curr Diab Rep (2010) 0.77
Blood pressure and diabetic nephropathy. Diabetes Care (2010) 0.76
Albuminuria reduction: the holy grail for kidney protection. Kidney Int (2007) 0.75
Dual blockade of the renin-angiotensin system in diabetic nephropathy. Diabetes Care (2009) 0.75
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences. J Clin Med (2015) 0.75
Aliskiren and valsartan combination therapy for the management of hypertension. Vasc Health Risk Manag (2010) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med (1997) 4.71
Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis (1999) 3.00
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res (1994) 2.82
Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation (1999) 2.45
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood (1997) 2.40
Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation (1995) 2.27
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest (1991) 2.02
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant (2005) 1.86
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia (2009) 1.86
Prazosin: preliminary report and comparative studies with other antihypertensive agents. Br Med J (1974) 1.76
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med (2000) 1.66
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant (2007) 1.61
Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract (2004) 1.60
Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res (2000) 1.57
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol (2007) 1.57
Diabetes: mellitus or lipidus? Diabetologia (2003) 1.55
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54
Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J (1994) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J (1998) 1.52
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51
Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial. Int J Clin Pract (2012) 1.50
Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol (2001) 1.49
Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther (1980) 1.49
Calcium handling proteins in the failing human heart. Basic Res Cardiol (1997) 1.48
Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron (1996) 1.48
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation. Transpl Infect Dis (2007) 1.48
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol (2009) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. Diabetes Metab Res Rev (2013) 1.47
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int (1993) 1.46
Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med (1977) 1.45
Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease. Br J Dermatol (2007) 1.44
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J (2011) 1.44
Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. Diabet Med (2005) 1.43
Hypertension: steps forward and steps backward. The Joint National Committee fifth report. Arch Intern Med (1993) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Prevalence of carpal tunnel syndrome and wrist osteoarthritis in long-term paraplegic patients compared with controls. J Hand Surg Eur Vol (2013) 1.41
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40
Measuring hypertensive cardiovascular risk: the vascular overload concept. Am Heart J (1994) 1.40
Evidence for a major gene affecting the transition from normoglycaemia to hyperglycaemia in Psammomys obesus. Heredity (Edinb) (2005) 1.40
Left ventricular hypertrophy and antihypertensive therapy. Am Fam Physician (1992) 1.40
The use of short-term ambulatory blood pressure monitoring in differing forms of hypertension. Clin Exp Hypertens A (1983) 1.40
Blood pressure measurement method not responsible for results of Brands et al. Am J Hypertens (1994) 1.39
Programmed bone-marrow donor for a leukaemic sibling, 10 years on. Lancet (1997) 1.39
The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica (1992) 1.39
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant (2007) 1.39
Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case. Eur J Pediatr (1992) 1.38
Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. Circ Res (1977) 1.37
Circulating catecholamine levels in human and experimental hypertension. Circ Res (1976) 1.37
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology (2006) 1.36
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol (2009) 1.36
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med (1976) 1.33
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bone Marrow Transplant (2011) 1.33
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
Differences in Ca(2+)-handling and sarcoplasmic reticulum Ca(2+)-content in isolated rat and rabbit myocardium. J Mol Cell Cardiol (2000) 1.30
Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 1.27
Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med (2000) 1.26
Beta-blockers and plasma renin activity in hypertension. Br Med J (1974) 1.25
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol (1994) 1.24
Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia (2010) 1.23
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res (1991) 1.22
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol (2001) 1.21
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. J Thromb Haemost (2009) 1.20
Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation (1998) 1.20
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant (2010) 1.20
A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr (1997) 1.20
Common femoral artery ligation and local debridement: a safe treatment for infected femoral artery pseudoaneurysms. J Vasc Surg (2001) 1.20
Influence of respiration on heart rate and blood pressure fluctuations. J Appl Physiol (1985) (1993) 1.19
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int (1999) 1.19
Monotherapy with labetalol compared with propranolol. Differential effects by race. J Clin Hypertens (1985) 1.18
Catecholamine metabolism in experimental hypertension in the rat. Circ Res (1967) 1.17
Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) (1996) 1.17
Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia (2005) 1.16
Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. Am J Cardiol (1998) 1.16
Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest (1988) 1.14
Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol (2001) 1.14
Single-agent and combination therapy of essential hypertension. Am Heart J (1984) 1.13
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis (2001) 1.13
Maggot therapy for the treatment of intractable wounds. Int J Dermatol (1999) 1.13
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract (2009) 1.13